Wilson's Disease Research - Treatment, Causes, Symptoms, Medication

Wilson's Disease Research Today is a free monthly online journal that collates and summarizes the latest research about Wilson's Disease, including details on treatment, causes, symptoms, medication.


Wilson's Disease Research Today

Home

View Latest Issue

Information About Wilson's Disease

Books on Wilson's Disease

Advertising in Research Today

View Other Research Today Publications



Volume 6 (2010), Issue 12 (December)

  1. Modelling the evolution and spread of HIV immune escape mutants.
    PLoS Pathog, 6(11): e1001196. [Abstract] [Full-text]
  2. Integrated genetic and epigenetic analysis identifies haplotype-specific methylation in the FTO type 2 diabetes and obesity susceptibility locus.
    PLoS One, 5(11): e14040. [Abstract] [Full-text]
  3. Bacillus Calmette-Guerin vaccination reduces the severity and progression of tuberculosis in badgers.
    Proc Biol Sci. [Abstract] [Full-text]
  4. Clinical features of Wilson disease: Analysis of 10 cases.
    Hepatol Res, 40(12): 1204-11. [Abstract] [Full-text]
  5. Bacillus Calmette-Guerin vaccination reduces the severity and progression of tuberculosis in badgers.
    Proc Biol Sci. [Abstract] [Full-text]
  6. Clinical features of Wilson disease: Analysis of 10 cases.
    Hepatol Res, 40(12): 1204-11. [Abstract] [Full-text]
  7. Anal cancer with cerebral metastasis: a case report.
    J Neurooncol, 101(1): 141-3. [Abstract] [Full-text]
  8. Anal cancer with cerebral metastasis: a case report.
    J Neurooncol, 101(1): 141-3. [Abstract] [Full-text]
  9. Anal cancer with cerebral metastasis: a case report.
    J Neurooncol, 101(1): 141-3. [Abstract] [Full-text]
  10. Navitoclax, a targeted high-affinity inhibitor of BCL-2, in lymphoid malignancies: a phase 1 dose-escalation study of safety, pharmacokinetics, pharmacodynamics, and antitumour activity.
    Lancet Oncol, 11(12): 1149-59. [Abstract] [Full-text]
  11. The first three years of screening for medium chain acyl-CoA dehydrogenase deficiency (MCADD) by newborn screening ontario.
    BMC Pediatr, 10: 82. [Abstract] [Full-text]
  12. Navitoclax, a targeted high-affinity inhibitor of BCL-2, in lymphoid malignancies: a phase 1 dose-escalation study of safety, pharmacokinetics, pharmacodynamics, and antitumour activity.
    Lancet Oncol, 11(12): 1149-59. [Abstract] [Full-text]
  13. Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome.
    Blood, 116(23): 4874-84. [Abstract] [Full-text]
  14. PCPP (poly[di(carboxylatophenoxy)-phosphazene]) microparticles co-encapsulating ovalbumin and CpG oligo-deoxynucleotides are potent enhancers of antigen specific Th1 immune responses in mice.
    Vaccine, 28(52): 8306-14. [Abstract] [Full-text]
  15. A novel triple adjuvant formulation promotes strong, Th1-biased immune responses and significant antigen retention at the site of injection.
    Vaccine, 28(52): 8288-99. [Abstract] [Full-text]
  16. PCPP (poly[di(carboxylatophenoxy)-phosphazene]) microparticles co-encapsulating ovalbumin and CpG oligo-deoxynucleotides are potent enhancers of antigen specific Th1 immune responses in mice.
    Vaccine, 28(52): 8306-14. [Abstract] [Full-text]
  17. A novel triple adjuvant formulation promotes strong, Th1-biased immune responses and significant antigen retention at the site of injection.
    Vaccine, 28(52): 8288-99. [Abstract] [Full-text]
  18. Long-term follow-up of Wilson disease: natural history, treatment, mutations analysis and phenotypic correlation.
    Liver Int, 31(1): 83-91. [Abstract] [Full-text]
  19. Long-term follow-up of Wilson disease: natural history, treatment, mutations analysis and phenotypic correlation.
    Liver Int, 31(1): 83-91. [Abstract] [Full-text]
  20. Long-term follow-up of Wilson disease: natural history, treatment, mutations analysis and phenotypic correlation.
    Liver Int, 31(1): 83-91. [Abstract] [Full-text]
  21. Clonal analysis of NRAS activating mutations in KIT-D816V systemic mastocytosis.
    Haematologica. [Abstract] [Full-text]
  22. Clonal analysis of NRAS activating mutations in KIT-D816V systemic mastocytosis.
    Haematologica. [Abstract] [Full-text]
  23. Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci.
    Nat Genet, 42(12): 1118-25. [Abstract] [Full-text]
  24. Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci.
    Nat Genet, 42(12): 1118-25. [Abstract] [Full-text]
  25. Thirty new loci for age at menarche identified by a meta-analysis of genome-wide association studies.
    Nat Genet, 42(12): 1077-85. [Abstract] [Full-text]
  26. 'Eating, eating is always there': food, consumerism and cardiovascular disease. Some evidence from Kerala, south India.
    Anthropol Med, 17(3): 261-75. [Abstract] [Full-text]
  27. 3,3'-Diindolylmethane inhibits migration and invasion of human cancer cells through combined suppression of ERK and AKT pathways.
    Oncol Rep. [Abstract] [Full-text]
  28. Rab7 Mutants Associated with Charcot-Marie-Tooth Disease Exhibit Enhanced NGF-Stimulated Signaling.
    PLoS One, 5(12): e15351. [Abstract] [Full-text]
  29. Cystatin C: a candidate biomarker for amyotrophic lateral sclerosis.
    PLoS One, 5(12): e15133. [Abstract] [Full-text]
  30. Nanomedicine in GI.
    Am J Physiol Gastrointest Liver Physiol. [Abstract] [Full-text]
  31. Receptor protein tyrosine phosphatases are novel components of a polycystin complex.
    Biochim Biophys Acta. [Abstract] [Full-text]
  32. Pediatric modification of the Montreal classification for inflammatory bowel disease: The Paris classification.
    Inflamm Bowel Dis. [Abstract] [Full-text]
  33. α-Fetoprotein Gene Delivery to the Nasal Epithelium of Nonhuman Primates by Human Parainfluenza Viral Vectors.
    Hum Gene Ther, 21(12): 1657-64. [Abstract] [Full-text]
  34. 'Eating, eating is always there': food, consumerism and cardiovascular disease. Some evidence from Kerala, south India.
    Anthropol Med, 17(3): 261-75. [Abstract] [Full-text]
  35. Rab7 mutants associated with Charcot-Marie-Tooth disease exhibit enhanced NGF-stimulated signaling.
    PLoS One, 5(12): e15351. [Abstract] [Full-text]
  36. Cystatin C: a candidate biomarker for amyotrophic lateral sclerosis.
    PLoS One, 5(12): e15133. [Abstract] [Full-text]
  37. Nanomedicine in GI.
    Am J Physiol Gastrointest Liver Physiol. [Abstract] [Full-text]
  38. Importance of surgical history in diagnosing mucopolysaccharidosis type II (Hunter syndrome): data from the Hunter Outcome Survey.
    Genet Med, 12(12): 816-22. [Abstract] [Full-text]
  39. Blood myeloid dendritic cells from HIV-1-infected individuals display a proapoptotic profile characterized by decreased Bcl-2 levels and by caspase-3+ frequencies that are associated with levels of plasma viremia and T cell activation in an exploratory study.
    J Virol, 85(1): 397-409. [Abstract] [Full-text]
  40. Genetics of childhood-onset inflammatory bowel disease.
    Inflamm Bowel Dis, 17(1): 346-61. [Abstract] [Full-text]
  41. Proinflammatory doses of diesel exhaust in healthy subjects fail to elicit equivalent or augmented airway inflammation in subjects with asthma.
    Thorax, 66(1): 12-9. [Abstract] [Full-text]
  42. α-Fetoprotein gene delivery to the nasal epithelium of nonhuman primates by human parainfluenza viral vectors.
    Hum Gene Ther, 21(12): 1657-64. [Abstract] [Full-text]
  43. Function of the intestinal epithelium and its dysregulation in inflammatory bowel disease.
    Inflamm Bowel Dis, 17(1): 382-95. [Abstract] [Full-text]
  44. Rab7 mutants associated with Charcot-Marie-Tooth disease exhibit enhanced NGF-stimulated signaling.
    PLoS One, 5(12): e15351. [Abstract] [Full-text]
  45. Cystatin C: a candidate biomarker for amyotrophic lateral sclerosis.
    PLoS One, 5(12): e15133. [Abstract] [Full-text]
  46. Nanomedicine in GI.
    Am J Physiol Gastrointest Liver Physiol. [Abstract] [Full-text]
  47. Blood myeloid dendritic cells from HIV-1-infected individuals display a proapoptotic profile characterized by decreased Bcl-2 levels and by caspase-3+ frequencies that are associated with levels of plasma viremia and T cell activation in an exploratory study.
    J Virol, 85(1): 397-409. [Abstract] [Full-text]
  48. Genetics of childhood-onset inflammatory bowel disease.
    Inflamm Bowel Dis, 17(1): 346-61. [Abstract] [Full-text]
  49. Proinflammatory doses of diesel exhaust in healthy subjects fail to elicit equivalent or augmented airway inflammation in subjects with asthma.
    Thorax, 66(1): 12-9. [Abstract] [Full-text]
  50. Function of the intestinal epithelium and its dysregulation in inflammatory bowel disease.
    Inflamm Bowel Dis, 17(1): 382-95. [Abstract] [Full-text]
  51. Blood myeloid dendritic cells from HIV-1-infected individuals display a proapoptotic profile characterized by decreased Bcl-2 levels and by caspase-3+ frequencies that are associated with levels of plasma viremia and T cell activation in an exploratory study.
    J Virol, 85(1): 397-409. [Abstract] [Full-text]
  52. Genetics of childhood-onset inflammatory bowel disease.
    Inflamm Bowel Dis, 17(1): 346-61. [Abstract] [Full-text]
  53. Proinflammatory doses of diesel exhaust in healthy subjects fail to elicit equivalent or augmented airway inflammation in subjects with asthma.
    Thorax, 66(1): 12-9. [Abstract] [Full-text]
  54. Function of the intestinal epithelium and its dysregulation in inflammatory bowel disease.
    Inflamm Bowel Dis, 17(1): 382-95. [Abstract] [Full-text]
  55. Multimorbidity - not just an older person's issue. Results from an Australian biomedical study.
    BMC Public Health, 10: 718. [Abstract] [Full-text]
  56. Systematic review: medical and nutritional interventions for the management of intestinal failure and its resultant complications in children.
    Aliment Pharmacol Ther, 33(2): 175-84. [Abstract] [Full-text]
  57. Systematic review: medical and nutritional interventions for the management of intestinal failure and its resultant complications in children.
    Aliment Pharmacol Ther, 33(2): 175-84. [Abstract] [Full-text]
  58. Application of oligonucleotide array CGH in the detection of a large intragenic deletion in POLG associated with Alpers Syndrome.
    Mitochondrion, 11(1): 104-7. [Abstract] [Full-text]
  59. Systematic review: medical and nutritional interventions for the management of intestinal failure and its resultant complications in children.
    Aliment Pharmacol Ther, 33(2): 175-84. [Abstract] [Full-text]
  60. Application of oligonucleotide array CGH in the detection of a large intragenic deletion in POLG associated with Alpers Syndrome.
    Mitochondrion, 11(1): 104-7. [Abstract] [Full-text]
  61. Systematic review: medical and nutritional interventions for the management of intestinal failure and its resultant complications in children.
    Aliment Pharmacol Ther, 33(2): 175-84. [Abstract] [Full-text]
  62. Application of oligonucleotide array CGH in the detection of a large intragenic deletion in POLG associated with Alpers Syndrome.
    Mitochondrion, 11(1): 104-7. [Abstract] [Full-text]
  63. Genotype-Phenotype Correlations among Pachyonychia Congenita Patients with K16 Mutations.
    J Invest Dermatol. [Abstract] [Full-text]
  64. Genotype-Phenotype Correlations among Pachyonychia Congenita Patients with K16 Mutations.
    J Invest Dermatol. [Abstract] [Full-text]
  65. Odor identification and mortality in old age.
    Chem Senses, 36(1): 63-7. [Abstract] [Full-text]
  66. Genotype-Phenotype Correlations among Pachyonychia Congenita Patients with K16 Mutations.
    J Invest Dermatol. [Abstract] [Full-text]
  67. Odor identification and mortality in old age.
    Chem Senses, 36(1): 63-7. [Abstract] [Full-text]
  68. Odor identification and mortality in old age.
    Chem Senses, 36(1): 63-7. [Abstract] [Full-text]
  69. Partitioning Reference Intervals by Use of Genetic Information.
    Clin Chem. [Abstract] [Full-text]
  70. Amantadine induced reversible corneal edema.
    J Clin Neurosci. [Abstract] [Full-text]
  71. Partitioning Reference Intervals by Use of Genetic Information.
    Clin Chem. [Abstract] [Full-text]
  72. Amantadine induced reversible corneal edema.
    J Clin Neurosci. [Abstract] [Full-text]
  73. Genetic variants within the MAP kinase signalling network and anti-TNF treatment response in rheumatoid arthritis patients.
    Ann Rheum Dis, 70(1): 98-103. [Abstract] [Full-text]
  74. Partitioning Reference Intervals by Use of Genetic Information.
    Clin Chem. [Abstract] [Full-text]
  75. Genetic variants within the MAP kinase signalling network and anti-TNF treatment response in rheumatoid arthritis patients.
    Ann Rheum Dis, 70(1): 98-103. [Abstract] [Full-text]
  76. Genetic variants within the MAP kinase signalling network and anti-TNF treatment response in rheumatoid arthritis patients.
    Ann Rheum Dis, 70(1): 98-103. [Abstract] [Full-text]
  77. Transcriptional and proteomic response of Pseudomonas aeruginosa PAO1 to spaceflight conditions involves Hfq regulation and reveals a role for oxygen.
    Appl Environ Microbiol. [Abstract] [Full-text]
  78. Prevalence of Visible Third Molars With Caries Experience or Periodontal Pathology in Middle-Aged and Older Americans.
    J Oral Maxillofac Surg. [Abstract] [Full-text]
  79. Drug-eluting stents versus coronary artery bypass grafting for the treatment of coronary artery disease: A meta-analysis of randomized and nonrandomized studies.
    J Thorac Cardiovasc Surg. [Abstract] [Full-text]
  80. Variation in Base Excision Repair Capacity.
    Mutat Res. [Abstract] [Full-text]
  81. Effect of the dose volume of perfluorocarbon when starting partial liquid ventilation.
    J Paediatr Child Health, 46(12): 714-22. [Abstract] [Full-text]
  82. Transcriptional and proteomic response of Pseudomonas aeruginosa PAO1 to spaceflight conditions involves Hfq regulation and reveals a role for oxygen.
    Appl Environ Microbiol. [Abstract] [Full-text]
  83. Prevalence of Visible Third Molars With Caries Experience or Periodontal Pathology in Middle-Aged and Older Americans.
    J Oral Maxillofac Surg. [Abstract] [Full-text]
  84. Drug-eluting stents versus coronary artery bypass grafting for the treatment of coronary artery disease: A meta-analysis of randomized and nonrandomized studies.
    J Thorac Cardiovasc Surg. [Abstract] [Full-text]
  85. Effect of the dose volume of perfluorocarbon when starting partial liquid ventilation.
    J Paediatr Child Health, 46(12): 714-22. [Abstract] [Full-text]
  86. Transcriptional and proteomic response of Pseudomonas aeruginosa PAO1 to spaceflight conditions involves Hfq regulation and reveals a role for oxygen.
    Appl Environ Microbiol. [Abstract] [Full-text]
  87. Drug-eluting stents versus coronary artery bypass grafting for the treatment of coronary artery disease: A meta-analysis of randomized and nonrandomized studies.
    J Thorac Cardiovasc Surg. [Abstract] [Full-text]
  88. The proteasome-ubiquitin pathway in the Schistosoma mansoni egg has development- and morphology-specific characteristics.
    Mol Biochem Parasitol, 175(2): 118-25. [Abstract] [Full-text]
  89. The proteasome-ubiquitin pathway in the Schistosoma mansoni egg has development- and morphology-specific characteristics.
    Mol Biochem Parasitol, 175(2): 118-25. [Abstract] [Full-text]
  90. The proteasome-ubiquitin pathway in the Schistosoma mansoni egg has development- and morphology-specific characteristics.
    Mol Biochem Parasitol, 175(2): 118-25. [Abstract] [Full-text]
  91. Presence and Significance of Microvesicular Steatosis in Nonalcoholic Fatty Liver Disease.
    J Hepatol. [Abstract] [Full-text]
  92. Dopexamine has no additional benefit in high-risk patients receiving goal-directed fluid therapy undergoing major abdominal surgery.
    Anesth Analg, 112(1): 130-8. [Abstract] [Full-text]
  93. Presence and Significance of Microvesicular Steatosis in Nonalcoholic Fatty Liver Disease.
    J Hepatol. [Abstract] [Full-text]
  94. Dopexamine has no additional benefit in high-risk patients receiving goal-directed fluid therapy undergoing major abdominal surgery.
    Anesth Analg, 112(1): 130-8. [Abstract] [Full-text]
  95. Colitis and intestinal inflammation in IL10-/- mice results from IL-13Rα2-mediated attenuation of IL-13 activity.
    Gastroenterology, 140(1): 254-64. [Abstract] [Full-text]
  96. KSR1 protects from interleukin-10 deficiency-induced colitis in mice by suppressing T-lymphocyte interferon-γ production.
    Gastroenterology, 140(1): 265-74. [Abstract] [Full-text]
  97. Presence and Significance of Microvesicular Steatosis in Nonalcoholic Fatty Liver Disease.
    J Hepatol. [Abstract] [Full-text]
  98. Dopexamine has no additional benefit in high-risk patients receiving goal-directed fluid therapy undergoing major abdominal surgery.
    Anesth Analg, 112(1): 130-8. [Abstract] [Full-text]
  99. Clinical features of idiopathic gastroparesis vary with sex, body mass, symptom onset, delay in gastric emptying, and gastroparesis severity.
    Gastroenterology, 140(1): 101-15. [Abstract] [Full-text]
  100. Colitis and intestinal inflammation in IL10-/- mice results from IL-13Rα2-mediated attenuation of IL-13 activity.
    Gastroenterology, 140(1): 254-64. [Abstract] [Full-text]
  101. KSR1 protects from interleukin-10 deficiency-induced colitis in mice by suppressing T-lymphocyte interferon-γ production.
    Gastroenterology, 140(1): 265-74. [Abstract] [Full-text]
  102. Dopexamine has no additional benefit in high-risk patients receiving goal-directed fluid therapy undergoing major abdominal surgery.
    Anesth Analg, 112(1): 130-8. [Abstract] [Full-text]
  103. Clinical features of idiopathic gastroparesis vary with sex, body mass, symptom onset, delay in gastric emptying, and gastroparesis severity.
    Gastroenterology, 140(1): 101-15. [Abstract] [Full-text]
  104. Colitis and intestinal inflammation in IL10-/- mice results from IL-13Rα2-mediated attenuation of IL-13 activity.
    Gastroenterology, 140(1): 254-64. [Abstract] [Full-text]
  105. KSR1 protects from interleukin-10 deficiency-induced colitis in mice by suppressing T-lymphocyte interferon-γ production.
    Gastroenterology, 140(1): 265-74. [Abstract] [Full-text]
  106. Evaluation of powder mixtures and hydrophilic gastroretentive drug delivery systems containing zinc acetate and sodium bicarbonate.
    J Pharm Biomed Anal, 54(4): 711-6. [Abstract] [Full-text]
  107. Evaluation of powder mixtures and hydrophilic gastroretentive drug delivery systems containing zinc acetate and sodium bicarbonate.
    J Pharm Biomed Anal, 54(4): 711-6. [Abstract] [Full-text]
  108. Evolution of an agriculture-associated disease causing Campylobacter coli clade: evidence from national surveillance data in Scotland.
    PLoS One, 5(12): e15708. [Abstract] [Full-text]
  109. Human Ago2 is required for efficient miR-122 regulation of HCV RNA accumulation and translation.
    J Virol. [Abstract] [Full-text]
  110. Dental considerations in the patient with Wilson's disease.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 111(1): 20-3. [Abstract] [Full-text]
  111. Periodontal disease and incident diabetes: a seven-year study.
    J Dent Res, 90(1): 41-6. [Abstract] [Full-text]
  112. Evolution of an agriculture-associated disease causing Campylobacter coli clade: evidence from national surveillance data in Scotland.
    PLoS One, 5(12): e15708. [Abstract] [Full-text]
  113. Human Ago2 is required for efficient miR-122 regulation of HCV RNA accumulation and translation.
    J Virol. [Abstract] [Full-text]
  114. Dental considerations in the patient with Wilson's disease.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 111(1): 20-3. [Abstract] [Full-text]
  115. Periodontal disease and incident diabetes: a seven-year study.
    J Dent Res, 90(1): 41-6. [Abstract] [Full-text]
  116. Dental considerations in the patient with Wilson's disease.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 111(1): 20-3. [Abstract] [Full-text]
  117. Periodontal disease and incident diabetes: a seven-year study.
    J Dent Res, 90(1): 41-6. [Abstract] [Full-text]
  118. 3,3'-Diindolylmethane inhibits migration and invasion of human cancer cells through combined suppression of ERK and AKT pathways.
    Oncol Rep, 25(2): 491-7. [Abstract] [Full-text]
  119. Neuromelanin activates microglia and induces degeneration of dopaminergic neurons: implications for progression of Parkinson's disease.
    Neurotox Res, 19(1): 63-72. [Abstract] [Full-text]
  120. The National Lung Screening Trial: overview and study design.
    Radiology, 258(1): 243-53. [Abstract] [Full-text]
  121. Neuromelanin activates microglia and induces degeneration of dopaminergic neurons: implications for progression of Parkinson's disease.
    Neurotox Res, 19(1): 63-72. [Abstract] [Full-text]
  122. 3,3'-diindolylmethane inhibits migration and invasion of human cancer cells through combined suppression of ERK and AKT pathways.
    Oncol Rep, 25(2): 491-7. [Abstract] [Full-text]
  123. The National Lung Screening Trial: overview and study design.
    Radiology, 258(1): 243-53. [Abstract] [Full-text]
  124. Neuromelanin activates microglia and induces degeneration of dopaminergic neurons: implications for progression of Parkinson's disease.
    Neurotox Res, 19(1): 63-72. [Abstract] [Full-text]
  125. 3,3'-diindolylmethane inhibits migration and invasion of human cancer cells through combined suppression of ERK and AKT pathways.
    Oncol Rep, 25(2): 491-7. [Abstract] [Full-text]
  126. 3,3'-diindolylmethane inhibits migration and invasion of human cancer cells through combined suppression of ERK and AKT pathways.
    Oncol Rep, 25(2): 491-7. [Abstract] [Full-text]
  127. Reversal of autophagy dysfunction in the TgCRND8 mouse model of Alzheimer's disease ameliorates amyloid pathologies and memory deficits.
    Brain, 134: 258-77. [Abstract] [Full-text]
  128. Zinc monotherapy is not as effective as chelating agents in treatment of Wilson disease.
    Gastroenterology. [Abstract] [Full-text]
  129. Receptor protein tyrosine phosphatases are novel components of a polycystin complex.
    Biochim Biophys Acta. [Abstract] [Full-text]
  130. Musculoskeletal pain is associated with incident mobility disability in community-dwelling elders.
    J Gerontol A Biol Sci Med Sci, 66(1): 82-8. [Abstract] [Full-text]
  131. A randomized controlled trial of communication training with primary care providers to improve patient-centeredness and health risk communication.
    Patient Educ Couns, 82(1): 21-9. [Abstract] [Full-text]
  132. Reversal of autophagy dysfunction in the TgCRND8 mouse model of Alzheimer's disease ameliorates amyloid pathologies and memory deficits.
    Brain, 134: 258-77. [Abstract] [Full-text]
  133. Zinc monotherapy is not as effective as chelating agents in treatment of Wilson disease.
    Gastroenterology. [Abstract] [Full-text]
  134. Musculoskeletal pain is associated with incident mobility disability in community-dwelling elders.
    J Gerontol A Biol Sci Med Sci, 66(1): 82-8. [Abstract] [Full-text]
  135. A randomized controlled trial of communication training with primary care providers to improve patient-centeredness and health risk communication.
    Patient Educ Couns, 82(1): 21-9. [Abstract] [Full-text]
  136. Reversal of autophagy dysfunction in the TgCRND8 mouse model of Alzheimer's disease ameliorates amyloid pathologies and memory deficits.
    Brain, 134: 258-77. [Abstract] [Full-text]
  137. Zinc monotherapy is not as effective as chelating agents in treatment of Wilson disease.
    Gastroenterology. [Abstract] [Full-text]
  138. Musculoskeletal pain is associated with incident mobility disability in community-dwelling elders.
    J Gerontol A Biol Sci Med Sci, 66(1): 82-8. [Abstract] [Full-text]
  139. A randomized controlled trial of communication training with primary care providers to improve patient-centeredness and health risk communication.
    Patient Educ Couns, 82(1): 21-9. [Abstract] [Full-text]
  140. Underrecognition of Elevated Blood Pressure Readings in Children After Early Repair of Coarctation of the Aorta.
    Pediatr Cardiol. [Abstract] [Full-text]
  141. Underrecognition of Elevated Blood Pressure Readings in Children After Early Repair of Coarctation of the Aorta.
    Pediatr Cardiol. [Abstract] [Full-text]
  142. Variation in base excision repair capacity.
    Mutat Res. [Abstract] [Full-text]
  143. Persistent pulmonary hypertension of the newborn is associated with mode of delivery and not with maternal use of selective serotonin reuptake inhibitors.
    Am J Perinatol, 28(1): 19-24. [Abstract] [Full-text]
  144. Variation in base excision repair capacity.
    Mutat Res. [Abstract] [Full-text]
  145. Persistent pulmonary hypertension of the newborn is associated with mode of delivery and not with maternal use of selective serotonin reuptake inhibitors.
    Am J Perinatol, 28(1): 19-24. [Abstract] [Full-text]
  146. Persistent pulmonary hypertension of the newborn is associated with mode of delivery and not with maternal use of selective serotonin reuptake inhibitors.
    Am J Perinatol, 28(1): 19-24. [Abstract] [Full-text]
Place a permanent text-link or advertisement here.

© 2005-2012 Wilson's Disease Research Today. All Rights Reserved.



Wilson's Disease Research Today Archive:

Volume 1 (2005)
  Issue 1 (March)
  Issue 2 (April)
  Issue 3 (May)
  Issue 4 (June)
  Issue 5 (July)
  Issue 6 (August)
  Issue 7 (September)
  Issue 8 (October)
  Issue 9 (November)
  Issue 10 (December)

Volume 2 (2006)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 3 (2007)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 4 (2008)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 5 (2009)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 6 (2010)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 7 (2011)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 8 (2012)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)



Wilson's Disease Books

New and Emerging Infectious Diseases, An Issue of Medical Clinics (The Clinics: Internal Medicine)

New and Emerging Infectious Diseases, An Issue of Medical Clinics (The Clinics: Internal Medicine)